Glycoprotein nonmetastatic melanoma protein B (GNMPB) as a novel biomarker for cerebral adrenoleukodystrophy
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Glycoprotein nonmetastatic melanoma protein B (GNMPB) as a novel biomarker for cerebral adrenoleukodystrophy
Authors
Keywords
-
Journal
Scientific Reports
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-05-14
DOI
10.1038/s41598-022-11552-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluation of cerebrospinal fluid glycoprotein NMB (GPNMB) as a potential biomarker for Alzheimer’s disease
- (2021) Freyja Aichholzer et al. Alzheimers Research & Therapy
- Amyotrophic Lateral Sclerosis: Molecular Mechanisms, Biomarkers, and Therapeutic Strategies
- (2021) Xiaoming Yang et al. Antioxidants
- Chitotriosidase attenuates brain inflammation via HDAC3/NF-κB pathway in D-galactose and aluminum-induced rat model with cognitive impairments
- (2021) Xingyan Yu et al. NEUROSCIENCE RESEARCH
- X‐linked adrenoleukodystrophy: Pathology, pathophysiology, diagnostic testing, newborn screening and therapies
- (2020) Bela R. Turk et al. INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE
- Transgenic Overexpression of GPNMB Protects Against MPTP-Induced Neurodegeneration
- (2020) Kevin M. Budge et al. MOLECULAR NEUROBIOLOGY
- Clinical and radiographic course of arrested cerebral adrenoleukodystrophy
- (2020) Eric J. Mallack et al. NEUROLOGY
- Volume of Gadolinium Enhancement and Successful Repair of the Blood-Brain Barrier in Cerebral Adrenoleukodystrophy
- (2020) Troy C. Lund et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- A report on state‐wide implementation of newborn screening for X‐linked Adrenoleukodystrophy
- (2019) Katie Wiens et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- The glycoprotein GPNMB is selectively elevated in the substantia nigra of Parkinson's disease patients and increases after lysosomal stress
- (2018) Elizabeth B. Moloney et al. NEUROBIOLOGY OF DISEASE
- Glycoprotein Non-Metastatic Protein B: An Emerging Biomarker for Lysosomal Dysfunction in Macrophages
- (2018) Martijn van der Lienden et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Glycoprotein NMB: a novel Alzheimer’s disease associated marker expressed in a subset of activated microglia
- (2018) Melanie Hüttenrauch et al. Acta Neuropathologica Communications
- Long-term outcome of patients with X-linked adrenoleukodystrophy: A retrospective cohort study
- (2017) Christel Tran et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy
- (2017) Florian Eichler et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gene Expression Profiling of Multiple Sclerosis Pathology Identifies Early Patterns of Demyelination Surrounding Chronic Active Lesions
- (2017) Debbie A. E. Hendrickx et al. Frontiers in Immunology
- GPNMB ameliorates mutant TDP-43-induced motor neuron cell death
- (2016) Yuki Nagahara et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Osteoactivin (GPNMB) ectodomain protein promotes growth and invasive behavior of human lung cancer cells
- (2016) Moses O. Oyewumi et al. Oncotarget
- Elevation of glycoprotein nonmetastatic melanoma protein B in type 1 Gaucher disease patients and mouse models
- (2016) Gertjan Kramer et al. FEBS Open Bio
- Intensity of MRI Gadolinium Enhancement in Cerebral Adrenoleukodystrophy: A Biomarker for Inflammation and Predictor of Outcome following Transplantation in Higher Risk Patients
- (2015) W.P. Miller et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Identification of a Biomarker in Cerebrospinal Fluid for Neuronopathic Forms of Gaucher Disease
- (2015) Hila Zigdon et al. PLoS One
- X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management
- (2012) Marc Engelen et al. Orphanet Journal of Rare Diseases
- Elevated Cerebral Spinal Fluid Cytokine Levels in Boys with Cerebral Adrenoleukodystrophy Correlates with MRI Severity
- (2012) Troy C. Lund et al. PLoS One
- Cerebrospinal Fluid Matrix Metalloproteinases Are Elevated in Cerebral Adrenoleukodystrophy and Correlate with MRI Severity and Neurologic Dysfunction
- (2012) Kathryn A. Thibert et al. PLoS One
- Outcomes after allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort report
- (2011) W. P. Miller et al. BLOOD
- Chitotriosidase as a biomarker of cerebral adrenoleukodystrophy
- (2011) Paul J Orchard et al. Journal of Neuroinflammation
- Hematopoietic growth factor inducible neurokinin-1 (Gpnmb/Osteoactivin) is a biomarker of progressive renal injury across species
- (2011) Mina Patel-Chamberlin et al. KIDNEY INTERNATIONAL
- Biochemical Aspects of X-Linked Adrenoleukodystrophy
- (2010) Stephan Kemp et al. BRAIN PATHOLOGY
- Peroxisomal Dysfunction in Inflammatory Childhood White Matter Disorders: An Unexpected Contributor to Neuropathology
- (2009) Inderjit Singh et al. JOURNAL OF CHILD NEUROLOGY
- Different content of chitin-like polysaccharides in multiple sclerosis and Alzheimer's disease brains
- (2008) Stefano Sotgiu et al. JOURNAL OF NEUROIMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now